Disorders of the thymus. A review

Area of Science:

• Immunology
• Oncology
• Endocrinology

Background:

• The thymus, a vital immune organ, is historically misunderstood.
• Its roles have shifted from being implicated in Sudden Infant Death Syndrome to its crucial function in immunosurveillance.
• Despite having only two main cell types, the thymus harbors diverse neoplasms.

Purpose of the Study:

• To elucidate the complex relationship between thymic neoplasms and associated parathymic syndromes.
• To highlight the prevalence of specific syndromes in patients with thymoma.
• To characterize the malignant potential of thymomas.

Main Methods:

• Review of existing literature on thymic neoplasms and parathymic syndromes.
• Analysis of epidemiological data linking thymoma to specific conditions.
• Histopathological classification of thymic tumors.

Main Results:

• Nearly 15 distinct thymic neoplasms exist, associated with over 20 parathymic syndromes.
• Approximately 40% of thymoma patients experience parathymic syndromes.
• Myasthenia gravis (MG), pure red cell aplasia (PRCA), and hypogammaglobulinemia are the most common syndromes.
• Thymomas are present in 15% of MG patients, 50% of PRCA patients, and 10% of hypogammaglobulinemia patients.
• 35% of all thymomas are malignant (invasive or metastatic).

Conclusions:

• Thymic disorders, particularly thymomas, are significantly associated with various systemic autoimmune and hematologic conditions.
• Understanding these associations is critical for comprehensive patient management.
• A substantial proportion of thymomas exhibit malignant characteristics, underscoring the need for vigilant diagnosis and treatment.